wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37731321-6F777299-A882-4E91-A525-B8E31E7A4FEC
Q37731321-6F777299-A882-4E91-A525-B8E31E7A4FEC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37731321-6F777299-A882-4E91-A525-B8E31E7A4FEC
Barriers to the Access of Bevacizumab in Patients with Solid Tumors and the Potential Impact of Biosimilars: A Physician Survey.
P2860
Q37731321-6F777299-A882-4E91-A525-B8E31E7A4FEC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37731321-6F777299-A882-4E91-A525-B8E31E7A4FEC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
57d2b9f0832e7cdd452a42e9d43d40ccd8216c7d
P2860
Clinical experience with Zarzio® in Europe: what have we learned?